Ginkgo reports Q2 2026 results and wins government contracts
Revenue fell 48% to $20 million, and Ginkgo will build autonomous labs for MIT, Caltech, Northwestern, and University of Maryland.
See the latest news and media coverage for Ginkgo. We track all announcements, press releases, and industry mentions in real time, all in one place.
Autonomous lab platform for biotechnology R&D
ginkgo.bioLast updated
In short: Ginkgo expanded its autonomous lab network and secured major government contracts despite reporting a decline in quarterly revenue to $20M.
Revenue fell 48% to $20 million, and Ginkgo will build autonomous labs for MIT, Caltech, Northwestern, and University of Maryland.
Its autonomous lab pairs frontier models with lab infrastructure to speed experimentation and cut costs.
The platform integrates data generation, AI-driven PK projection, and compound management for early-stage drug discovery.
It uses Nebula, an autonomous lab, to produce pharmaceuticals domestically, achieving a milestone with GFP production.
Detailed price information for Ginkgo Bioworks Holdings (DNA-N) from The Globe and Mail including charting and trades.
In other recent news, Ginkgo Bioworks Holdings reported its financial results for the second quarter of 2026, revealing a significant revenue shortfall. The company’s revenue...
Ginkgo Bioworks has on 05.08.2026 at the financial conference presented the quarterly figures for the most recent quarter - reporting date 30.06.2026 ...
Risk warning: Trading in financial instruments and/or cryptocurrencies involves a high risk, such as the chance that you will lose all or part of the...
Track Ginkgo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.